Stephen TukwasibweIsaac SsewanyanaGerald MboowaIvan SserwaddaJoaniterNankabirwaEmmanuel ArinaitweIsaac SsewanyanaYoweri TaremwaGerald TumusiimeMoses R. KamyaPrasanna JagannathanAnnettee Nakimuli2024-04-222024-04-222023-04-21Tukwasibwe, S., Mboowa, G., Sserwadda, I. et al. Impact of high human genetic diversity in Africa on immunogenicity and efficacy of RTS,S/AS01 vaccine. Immunogenetics 75, 207–214 (2023). https://doi.org/10.1007/s00251-023-01306-8https://doi.org/10.1007/s00251-023-01306-8https://hdl.handle.net/20.500.11951/1218Journal ArticleIn modern medicine, vaccination is one of the most effective public health strategies to prevent infectious diseases. Indisputably, vaccines have saved millions of lives by reducing the burden of many serious infections such as polio, tuberculosis, measles, pneumonia, and tetanus. Despite the recent recommendation by the World Health Organization (WHO) to roll out RTS,S/AS01, this malaria vaccine still faces major challenges of variability in its efficacy partly due to high genetic variation in humans and malaria parasites. Immune responses to malaria vary between individuals and populations. Human genetic variation in immune system genes is the probable cause for this heterogeneity. In this review, we will focus on human genetic factors that determine variable responses to vaccination and how variation in immune system genes affect the immunogenicity and efficacy of the RTS,S/AS01 vaccine.enArticle